295 related articles for article (PubMed ID: 29337050)
21. Nav1.1 localizes to axons of parvalbumin-positive inhibitory interneurons: a circuit basis for epileptic seizures in mice carrying an Scn1a gene mutation.
Ogiwara I; Miyamoto H; Morita N; Atapour N; Mazaki E; Inoue I; Takeuchi T; Itohara S; Yanagawa Y; Obata K; Furuichi T; Hensch TK; Yamakawa K
J Neurosci; 2007 May; 27(22):5903-14. PubMed ID: 17537961
[TBL] [Abstract][Full Text] [Related]
22. Early-life febrile seizures worsen adult phenotypes in Scn1a mutants.
Dutton SBB; Dutt K; Papale LA; Helmers S; Goldin AL; Escayg A
Exp Neurol; 2017 Jul; 293():159-171. PubMed ID: 28373025
[TBL] [Abstract][Full Text] [Related]
23. Antisense oligonucleotides restore excitability, GABA signalling and sodium current density in a Dravet syndrome model.
Yuan Y; Lopez-Santiago L; Denomme N; Chen C; O'Malley HA; Hodges SL; Ji S; Han Z; Christiansen A; Isom LL
Brain; 2024 Apr; 147(4):1231-1246. PubMed ID: 37812817
[TBL] [Abstract][Full Text] [Related]
24. Functional and structural deficits of the dentate gyrus network coincide with emerging spontaneous seizures in an Scn1a mutant Dravet Syndrome model during development.
Tsai MS; Lee ML; Chang CY; Fan HH; Yu IS; Chen YT; You JY; Chen CY; Chang FC; Hsiao JH; Khorkova O; Liou HH; Yanagawa Y; Lee LJ; Lin SW
Neurobiol Dis; 2015 May; 77():35-48. PubMed ID: 25725421
[TBL] [Abstract][Full Text] [Related]
25. dCas9-Based Scn1a Gene Activation Restores Inhibitory Interneuron Excitability and Attenuates Seizures in Dravet Syndrome Mice.
Colasante G; Lignani G; Brusco S; Di Berardino C; Carpenter J; Giannelli S; Valassina N; Bido S; Ricci R; Castoldi V; Marenna S; Church T; Massimino L; Morabito G; Benfenati F; Schorge S; Leocani L; Kullmann DM; Broccoli V
Mol Ther; 2020 Jan; 28(1):235-253. PubMed ID: 31607539
[TBL] [Abstract][Full Text] [Related]
26. Ndnf Interneuron Excitability Is Spared in a Mouse Model of Dravet Syndrome.
Liebergall SR; Goldberg EM
J Neurosci; 2024 Apr; 44(17):. PubMed ID: 38443186
[TBL] [Abstract][Full Text] [Related]
27. Vasoactive intestinal peptide-expressing interneurons are impaired in a mouse model of Dravet syndrome.
Goff KM; Goldberg EM
Elife; 2019 Jul; 8():. PubMed ID: 31282864
[TBL] [Abstract][Full Text] [Related]
28. Scn1a dysfunction alters behavior but not the effect of stress on seizure response.
Sawyer NT; Helvig AW; Makinson CD; Decker MJ; Neigh GN; Escayg A
Genes Brain Behav; 2016 Mar; 15(3):335-47. PubMed ID: 26694226
[TBL] [Abstract][Full Text] [Related]
29. Nav1.2 is expressed in caudal ganglionic eminence-derived disinhibitory interneurons: Mutually exclusive distributions of Nav1.1 and Nav1.2.
Yamagata T; Ogiwara I; Mazaki E; Yanagawa Y; Yamakawa K
Biochem Biophys Res Commun; 2017 Sep; 491(4):1070-1076. PubMed ID: 28784306
[TBL] [Abstract][Full Text] [Related]
30. Impairment of Sharp-Wave Ripples in a Murine Model of Dravet Syndrome.
Cheah CS; Lundstrom BN; Catterall WA; Oakley JC
J Neurosci; 2019 Nov; 39(46):9251-9260. PubMed ID: 31537705
[TBL] [Abstract][Full Text] [Related]
31. Specific deletion of NaV1.1 sodium channels in inhibitory interneurons causes seizures and premature death in a mouse model of Dravet syndrome.
Cheah CS; Yu FH; Westenbroek RE; Kalume FK; Oakley JC; Potter GB; Rubenstein JL; Catterall WA
Proc Natl Acad Sci U S A; 2012 Sep; 109(36):14646-51. PubMed ID: 22908258
[TBL] [Abstract][Full Text] [Related]
32. Deletion of a non-canonical regulatory sequence causes loss of Scn1a expression and epileptic phenotypes in mice.
Haigh JL; Adhikari A; Copping NA; Stradleigh T; Wade AA; Catta-Preta R; Su-Feher L; Zdilar I; Morse S; Fenton TA; Nguyen A; Quintero D; Agezew S; Sramek M; Kreun EJ; Carter J; Gompers A; Lambert JT; Canales CP; Pennacchio LA; Visel A; Dickel DE; Silverman JL; Nord AS
Genome Med; 2021 Apr; 13(1):69. PubMed ID: 33910599
[TBL] [Abstract][Full Text] [Related]
33. Corticohippocampal circuit dysfunction in a mouse model of Dravet syndrome.
Mattis J; Somarowthu A; Goff KM; Jiang E; Yom J; Sotuyo N; Mcgarry LM; Feng H; Kaneko K; Goldberg EM
Elife; 2022 Feb; 11():. PubMed ID: 35212623
[TBL] [Abstract][Full Text] [Related]
34. Genetic background modulates impaired excitability of inhibitory neurons in a mouse model of Dravet syndrome.
Rubinstein M; Westenbroek RE; Yu FH; Jones CJ; Scheuer T; Catterall WA
Neurobiol Dis; 2015 Jan; 73():106-17. PubMed ID: 25281316
[TBL] [Abstract][Full Text] [Related]
35. Interneuron Dysfunction in a New Mouse Model of SCN1A GEFS.
Das A; Zhu B; Xie Y; Zeng L; Pham AT; Neumann JC; Safrina O; Benavides DR; MacGregor GR; Schutte SS; Hunt RF; O'Dowd DK
eNeuro; 2021; 8(2):. PubMed ID: 33658306
[TBL] [Abstract][Full Text] [Related]
36. Cell-Selective Adeno-Associated Virus-Mediated
Tanenhaus A; Stowe T; Young A; McLaughlin J; Aeran R; Lin IW; Li J; Hosur R; Chen M; Leedy J; Chou T; Pillay S; Vila MC; Kearney JA; Moorhead M; Belle A; Tagliatela S
Hum Gene Ther; 2022 Jun; 33(11-12):579-597. PubMed ID: 35435735
[TBL] [Abstract][Full Text] [Related]
37. Fine Mapping of a Dravet Syndrome Modifier Locus on Mouse Chromosome 5 and Candidate Gene Analysis by RNA-Seq.
Hawkins NA; Zachwieja NJ; Miller AR; Anderson LL; Kearney JA
PLoS Genet; 2016 Oct; 12(10):e1006398. PubMed ID: 27768696
[TBL] [Abstract][Full Text] [Related]
38. Epilepsy phenotype associated with a chromosome 2q24.3 deletion involving SCN1A: Migrating partial seizures of infancy or atypical Dravet syndrome?
Lim BC; Hwang H; Kim H; Chae JH; Choi J; Kim KJ; Hwang YS; Yum MS; Ko TS
Epilepsy Res; 2015 Jan; 109():34-9. PubMed ID: 25524840
[TBL] [Abstract][Full Text] [Related]
39. Neuropathological Characterization of a Dravet Syndrome Knock-In Mouse Model Useful for Investigating Cannabinoid Treatments.
Satta V; Alonso C; Díez P; Martín-Suárez S; Rubio M; Encinas JM; Fernández-Ruiz J; Sagredo O
Front Mol Neurosci; 2020; 13():602801. PubMed ID: 33584198
[TBL] [Abstract][Full Text] [Related]
40. Aberrant regulation of a poison exon caused by a non-coding variant in a mouse model of Scn1a-associated epileptic encephalopathy.
Voskobiynyk Y; Battu G; Felker SA; Cochran JN; Newton MP; Lambert LJ; Kesterson RA; Myers RM; Cooper GM; Roberson ED; Barsh GS
PLoS Genet; 2021 Jan; 17(1):e1009195. PubMed ID: 33411788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
